Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    Pheochromocytoma

    Pheochromocytoma supports researchers conducting scientific studies and clinical trials to improve diagnosis, understand disease mechanisms, and advance new or better therapies for this rare tumor.

    Browse similar grants
    Cancer Research Grants 2026Foundation Grants for Biomedical Research
    OverviewSimilar Grants
    OverviewSimilar Grants

    Funder: National Organization for Rare Disorders

    Due Dates: January 19, 2027, 11:59 pm PT (Letter of Intent / Initial Application) | March 2027 (Full proposal invitations) | June 2027 (Award announcements)

    Funding Amounts: One grant up to US$50,000 for a one- or two-year project

    Summary: Supports scientific and clinical research on pheochromocytoma to improve diagnosis, understand disease mechanisms, and advance new or better therapies.

    Key Information: Open to researchers worldwide, with strong preference for faculty-level or senior scientists at academic or nonprofit institutions or foundations.


    Description

    The National Organization for Rare Disorders (NORD), supported by donations from the pheochromocytoma community, offers this disease-specific opportunity through its Rare Disease Research Grants Program. The program supports scientific and clinical studies designed to improve diagnosis, deepen understanding of underlying disease mechanisms, or improve therapy for pheochromocytoma, a rare tumor that typically develops in the adrenal gland.

    The award is intended to help qualified researchers initiate scientific studies or clinical trials whose results could secure further support from the NIH, FDA, other funding agencies, or a corporate sponsor. Ideally, the work will have the potential to lead to a new or better therapy. Selection emphasizes scientific merit and the potential for high-quality, high-impact research.


    Atom

    See the full grant listing

    Sign in to view full eligibility details, sources, similar grants, and AI-powered analysis.